GLP-1 and GIP Analogues for Weight Loss:
Semaglutide (Wegovy/Ozempic) and Tirzepatide (Mounjaro) are weekly injectable medications used for effective weight loss, especially when diet and exercise alone haven’t worked. These drugs mimic gut hormones — GLP-1 and GIP — which help regulate appetite, digestion, and blood sugar.
-
Semaglutide targets GLP-1 only, reducing hunger and slowing digestion, with around 15% average weight loss.
-
Tirzepatide targets both GLP-1 and GIP, offering stronger effects on appetite and metabolism, with up to 20%+ weight loss in trials.
Key Differences:
-
Tirzepatide offers more potent weight loss.
-
Both are weekly injections.
-
Side effects include nausea and digestive issues, with Tirzepatide potentially causing slightly more.
Niva Medical Clinic provides personalised, medically supervised weight loss programmes — unlike generic online services — with in-person assessments, GP monitoring, and lifestyle support. They serve patients across North West London and Hertfordshire.